Suicide, depression, and isotretinoin: Is there a causal link?

Journal of the American Academy of Dermatology

Volumn 45, Issue 5, 2001, Pages

  Jacobs, Douglas G ^a,b,c   Deutsch, Nancy L ^a,c   Brewer, Margaret ^a,c  

^a Screening for Mental Health Inc   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Professional Psychiatric Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN;

AFFECTIVE NEUROSIS; CONFERENCE PAPER; DEPRESSION; DRUG INDUCED DISEASE; DRUG MECHANISM; PATIENT MONITORING; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; SUICIDE;

EID: 0034758740     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2001.118233     Document Type: Conference Paper

References (47)

1. The development of retinoids in dermatology
2. Prolonged remissions of cystic and conglobate acne with 13-cis-retinoic acid
3. Retinoid receptors
4. Isotretinoin differs from other synthetic retinoids in its modulation of human cellular retinoic acid binding protein (CRABP)
5. In situ hybridization analysis of CRABP II expression in sebaceous follicles from 13-cis-retinoic acid-treated acne patients
6. Retinoic acid receptors and retinoid X receptors: Interactions with endogenous retinoic acids
7. Ligand specificities of recombinant retinoic acid receptors RAR alpha and RAR beta
8. The human sebocyte culture model provides new insights into development and management of seborrhoea and acne
9. 13-cis-retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans retinoic acid and binding to retinoid acid receptors
10. Suicide and stress-related dermatoses
11. Dermatological non-disease: A common and potentially fatal disturbance of cutaneous body image
12. Skin disease and handicap: An analysis of the impact of skin conditions
13. Psychiatric aspects of the treatment of mild to moderate facial acne. Some preliminary observations
14. Psychiatric profile of patients with neurodermatitis
15. Suicide in dermatological patients
16. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis
17. Isotretinoin intoxication in attempted suicide
18. Psychiatric reactions to the retinoids
19. Isotretinoin and depression: Care is needed
20. Depression associated with isotretinoin therapy
21. Isotretinoin therapy and depression: Evidence for an association
22. Depression - A side effect of 13-cis-retinoic acid therapy
23. Acute depression from isotretinoin
24. Adverse reactions to isotretinoin. A report from the Adverse Drug Reaction Reporting System
25. Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin
26. Management of adult acne and acne variants
27. Safety of Accutane with possible depression
28. Side effects of acne therapy and their management
29. Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suitable
30. A rating scale for depression
31. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States
32. The psychological autopsy: A useful tool for determining proximate causation in suicide cases
33. Drug-induced depression
34. Mental disorders due to a general medical condition and substance-induced disorders: Mood, psychotic, catatonic, and personality disorders
35. Beta-blockers and depression. Evidence against an association
36. Prevalence of major depressive disorder in patients receiving beta-blocker therapy versus other medications
37. An essential role for retinoid receptors RAR beta and RXR gamma in long-term potentiation and depression
38. Regulation of dopaminergic pathways by retinoids: Activation of the D2 receptor promoter by members of the retinoic acid receptor-retinoid X receptor family
39. High levels of a retinoic acid-generating dehydrogenase in the meso-telencephalic dopamine system
40. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors
41. Impaired locomotion and dopamine signaling in retinoid receptor mutant mice